| Amber Lynn Willson, MS, CCC-S | |
|
130 George St, Beckley, WV 25801-2648 | |
| (304) 929-2665 | |
| Not Available |
| Full Name | Amber Lynn Willson |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 130 George St, Beckley, West Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083832489 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | SLP-0964 (West Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Amber Lynn Willson, MS, CCC-S 1653 Scott Ridge Rd, Beaver, WV 25813-9469 Ph: (304) 763-3463 | Amber Lynn Willson, MS, CCC-S 130 George St, Beckley, WV 25801-2648 Ph: (304) 929-2665 |
News Archive
Itamar Medical, the leader in non-invasive vascular health diagnostics, announced today that an agreement has been signed with Roche by which Itamar will develop an EndoPAT device designated for use with animal models, enabling pre-clinical studies examining the efficacy of various compounds in the early stage of drug development essential for later stage development in humans.
Millennium: The Takeda Oncology Company with its parent company Takeda Pharmaceutical Company Limited today announced updated results from a phase 2 study of orteronel, a selective oral 17,20 lyase inhibitor, dosed without prednisone in patients with non-metastatic castration resistant prostate cancer (nmCRPC) and rising prostate-specific antigen.
Optimer Pharmaceuticals, Inc. today announced the pricing of a previously announced underwritten public offering of 6,000,000 shares of its common stock, offered at a price to the public of $11.25 per share. The gross proceeds to Optimer from this offering are expected to be $67.5 million, before deducting the underwriting discounts and commissions and other estimated offering expenses payable by Optimer.
The U.S. Food and Drug Administration today cleared the first contact lens to incorporate an additive that automatically darkens the lens when exposed to bright light.
Researchers at Okayama University describe in the journal Scientific Reports the role of an extracellular protein, versican, in regulating tumor growth and providing a newly formed network of blood vessels to further nourish the tumor.
› Verified 4 days ago
Paulette Lilly, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 105 Adair St, Beckley, WV 25801 Phone: 304-256-4712 | |
Roark And Roark Inc. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 922b S Eisenhower Dr, Beckley, WV 25801 Phone: 304-228-4895 | |
Rebbecca Rexrode, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 400 Neville St, Beckley, WV 25801 Phone: 304-256-4712 | |
Mrs. Marsha Smith Fink, MS CCCL SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 105 Adair St, Raleigh Co Board Of Education, Beckley, WV 25801 Phone: 304-256-4500 | |
Carmen Ball, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 400 Neville St, Beckley, WV 25801 Phone: 304-256-4712 | |
Giana Hunsaker, MS, CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1769 Robert C Byrd Dr, Beckley, WV 25801 Phone: 304-860-1048 |